Drug interactions between cyclosporine and Neoral
Interactions between your drugs
There were no interactions found in our database between cyclosporine and Neoral - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Cyclosporine is in the drug class calcineurin inhibitors.
- Cyclosporine is used to treat the following conditions:
- Cogan's Syndrome
- Crohn's Disease
- Evan's Syndrome
- Focal Segmental Glomerulosclerosis
- Graft-versus-host disease
- Idiopathic Thrombocytopenic Purpura
- Inflammatory Bowel Disease
- Nephrotic Syndrome
- Organ Transplant, Rejection Prophylaxis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Ulcerative Colitis
- Ulcerative Colitis, Active
- Neoral is a member of the drug class calcineurin inhibitors.
- Neoral is used to treat the following conditions:
Drug and food interactions
Applies to: cyclosporine and Neoral (cyclosporine)
Grapefruit and grapefruit juice can increase the levels of cycloSPORINE in your body and should generally not be consumed during treatment. High blood levels of cycloSPORINE can lead to increased risk of serious side effects on kidney, liver, and nervous system functions. If you regularly consume grapefruits or grapefruit juice, you should be monitored for side effects and/or changes in cycloSPORINE levels. However, do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. You should also take cycloSPORINE on a consistent schedule with regard to time of day and relation to meals. Let your doctor know if you experience fever, rash, nausea, vomiting, abdominal pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes), decreased urination, excessive thirst, swelling, weight gain, dizziness, fatigue, weakness, headache, blurred vision, numbness/burning/tingling in the hand and feet, tremors, or convulsions, as they may be symptoms caused by excessive effects of cycloSPORINE.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
The recommended maximum number of medicines in the 'undecapeptide immunosuppressants' category to be taken concurrently is usually one. Your list includes one medicines belonging to the 'undecapeptide immunosuppressants' category:
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.